Ares Financial Consulting’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$12.3K Sell
94
-3
-3% -$449 0.01% 519
2026
Q2
$14.8K Sell
97
-12
-11% -$2K 0.01% 483
2026
Q1
$22.6K Buy
109
+86
+374% +$21.6K 0.02% 370
2025
Q4
$6.54K Buy
+23
New +$7.19K 0.01% 426

Other funds holding PODD

Ares Financial Consulting's PODD Position: Q3 2026 in Review

Ares Financial Consulting reduced its Insulet (PODD) stake by 3.1% in Q3 2026, selling an estimated $449 and leaving 94 shares worth $12.3K. The position accounts for 0.01% of the portfolio, ranked #519.

Ares Financial Consulting first reported a position in PODD in Q4 2025 and has held it in 4 quarters since. The position peaked at $22.6K in Q1 2026. 317 funds tracked by Wall St. Rank hold PODD as of Q3 2026.

  • Ares Financial Consulting held 94 shares of Insulet worth $12.3K as of Q3 2026.
  • Ares Financial Consulting sold 3 Insulet shares in Q3 2026, an estimated $449.
  • Insulet made up 0.01% of Ares Financial Consulting's portfolio in Q3 2026, its #519 holding.
  • Ares Financial Consulting first reported a position in Insulet in Q4 2025 and has held it in 4 quarters since.
  • Ares Financial Consulting's Insulet position peaked at $22.6K in Q1 2026.
  • 317 funds tracked by Wall St. Rank held Insulet as of Q3 2026.

Based on Ares Financial Consulting's 13F filing for Q3 2026, filed 19 Oct 2026.